Politics
Prescription drug advertising is facing renewed scrutiny from the FDA and bipartisan lawmakers, Axios reports
News detail
The FDA says many ads and social media posts fail fair-balance standards, though tougher rules could face industry resistance and First Amendment challenges Proposals range from tighter enforcement and pre-screening, to tax penalties or an outright ban
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.